BARDA provides CDMO $628m to serve US government 02-Jun-2020 By Ben Hargreaves Emergent receives funds to provide manufacturing capabilities to the US government for COVID-19 vaccine candidates.
Novavax expands COVID-19 vaccine manufacturing through acquisition 02-Jun-2020 By Ben Hargreaves Novavax buys Praha Vaccines and gains the capacity to produce over one billion doses of its COVID-19 vaccine candidate.
First antibody treatment designed against COVID-19 hits trials 02-Jun-2020 By Ben Hargreaves Eli Lilly’s potential treatment is the first coronavirus-specific mAb to enter trials and large-scale manufacturing efforts will commence immediately.
AZ agrees commercial manufacturing deal for COVID-19 vaccine 01-Jun-2020 By Ben Hargreaves Oxford Biomedica signs on to produce clinical and commercial supply of AZD1222, which recently entered late-stage trials.
GSK to ramp up vaccine adjuvant production to 1bn doses 29-May-2020 By Ben Hargreaves The company will supply the adjuvant to partners’ COVID-19 vaccine candidates, without expecting to profit from sales.
AbCellera in COVID-19 antibody discovery pact with Eli Lilly 26-May-2020 By Ben Hargreaves The two companies will partner to work on the discovery of nine antibodies, with the initial target being COVID-19-related.
Merck leaps into COVID-19 battle with three developments 26-May-2020 By Ben Hargreaves The company announces three deals on the same day, including an acquisition and two partnership deals against COVID-19.
UPDATED AZ receives $1.2bn from BARDA for coronavirus vaccine 22-May-2020 By Ben Hargreaves AZ and Oxford University receive injection of capital for the manufacture of 300 million doses of vaccine.
UPDATED Tracking the latest therapies for COVID-19 20-May-2020 By Ben Hargreaves BioPharma-Reporter runs down the latest numbers from the pipeline of therapies and vaccines for the novel coronavirus.
UK injects funds into COVID-19 vaccine, puts citizens front of queue 19-May-2020 By Ben Hargreaves UK government will invest into an existing vaccine developed by the Oxford University and will speed up completion of a vaccine manufacturing center.
Moderna's speedy COVID-19 vaccine results not possible alongside CMO, says CEO 19-May-2020 By Ben Hargreaves Moderna’s CEO comments on positive early results by highlighting the importance of its own manufacturing capabilities.
Sanofi retracts US-first stance on COVID-19 vaccine 18-May-2020 By Ben Hargreaves The French company bows to pressure from the French government to state that there will be no preferential supply to US of potential vaccine.
US outlines plan for readying coronavirus vaccine by start of 2021 18-May-2020 By Ben Hargreaves The US government provided details on ‘Operation Warp Speed’ and who will take leadership of the project.
US strikes $138m deal to ensure enough syringes for COVID-19 vaccine 13-May-2020 By Ben Hargreaves US HHS provides funding in order to boost the number of prefilled syringes available for potential vaccine against coronavirus.
Pfizer to outsource brand products, making space for COVID-19 vaccine 12-May-2020 By Ben Hargreaves Pfizer looks to outsource more of its vaccine and intravenous drugs to free up capacity for potential COVID-19 vaccine.
Novavax receives record $388m funding for COVID-19 vaccine 12-May-2020 By Ben Hargreaves CEPI awards Novavax highest investment to date, with the biotech progressing candidate into trials and partners with Emergent for production.
Pfizer and BioNTech work to scale up COVID-19 vaccine production 11-May-2020 By Ben Hargreaves Pfizer identifies four facilities globally to produce vaccine, while BioNTech will increase production at its German facilities.
Regeneron devotes New York facility to COVID-19 cocktail treatment 11-May-2020 By Ben Hargreaves Regeneron expects an antibody cocktail against coronavirus to be ready for trials in June, plans to utilize entire facility for production.
How to prevent another COVID-19? ‘Invest in infrastructure’ 06-May-2020 By Ben Hargreaves CEO of Berkeley Lights talks about the company’s work to identify antibodies against COVID-19 and what the long-term picture looks like.
Lonza and Moderna shoot for billion COVID-19 vaccine doses 05-May-2020 By Ben Hargreaves Moderna announces it has partnered with Lonza with the aim of producing one billion doses annually.
Ajinomoto to produce potential COVID-19 treatment for CytoDyn 05-May-2020 By Ben Hargreaves Ajinomoto agrees partnership to manufacture leronlimab, which is currently undergoing clinical trials for the treatment of COVID-19.
COVID-19 vaccine in one year ‘wishful thinking’ 04-May-2020 By Ben Hargreaves The likelihood of an effective vaccine being developed and scaled up in less than 12 months is unrealistic, suggests GlobalData analyst.
Catalent takes on manufacture of J&J’s coronavirus vaccine 30-Apr-2020 By Ben Hargreaves Catalent announces partnership with J&J to manufacture lead COVID-19 vaccine candidate, plans to hire 300 staff and manufacture 24/7.
AZ and Oxford University partner to develop coronavirus vaccine 30-Apr-2020 By Ben Hargreaves Under the agreement, AZ will develop, manufacture and distribute the vaccine that has already begun Phase I trials.
Hired & Retired: Changes amid COVID-19 29-Apr-2020 By Ben Hargreaves As the industry shifts gears to combat the novel coronavirus, a number of leadership changes have taken place.
World leaders work on $8bn vaccine fund effort 28-Apr-2020 By Ben Hargreaves The WHO and world leaders commit to a fund to accelerate development of vaccines, tests and treatments for COVID-19.
J&J strikes CDMO deal to add capacity for COVID-19 vaccine 27-Apr-2020 By Ben Hargreaves J&J agrees a manufacturing partnership with Emergent, as it looks to hit its target of one billion doses.
UPDATED Director of BARDA leaves position amid pandemic 22-Apr-2020 By Ben Hargreaves Rick Bright confirmed as having left his position as director of BARDA as the agency provides aid to develop solutions for COVID-19.
Regeneron’s Ebola treatment given US priority review 21-Apr-2020 By Ben Hargreaves Regeneron’s triple antibody treatment for the Ebola virus has been provided US FDA priority review to speed regulatory action.
Manufacturing alliance set to scale Oxford University coronavirus vaccine 20-Apr-2020 By Ben Hargreaves Halix joins a consortium to produce Oxford University’s vaccine, after first patient enrolled to clinical trial.
UK forms COVID taskforce to bring vaccine to public 20-Apr-2020 By Ben Hargreaves UK government brings together AZ, BIA and Wellcome to speed up clinical trials and scale manufacturing of potential vaccines.
BARDA awards $483m to scale production of Moderna’s COVID vaccine 17-Apr-2020 By Ben Hargreaves With recruitment for Phase I trials complete, Moderna receives funds to expand manufacturing capacity ready for late-stage trials.
‘No company can go it alone’: GSK and Sanofi partner against coronavirus 15-Apr-2020 By Ben Hargreaves Two of the largest companies in the pharma industry, and specialists in developing vaccines, pool resources to develop a vaccine for COVID-19.
How is the supply chain for immunotherapies impacted by COVID-19? 15-Apr-2020 By Ben Hargreaves COO of Dendreon explains how ‘every part’ of the supply chain for the company’s lead product has been affected by the novel coronavirus.
Vir continues to build production for COVID-19 antibody 14-Apr-2020 By Ben Hargreaves In its latest manufacturing partnership, Vir announces that it will work with Samsung Biologics for large-scale production.
Pfizer and BioNTech preparing ‘millions’ of COVID mRNA vaccines 14-Apr-2020 By Ben Hargreaves Pfizer and BioNTech provide further details on their work against COVID-19, including clinical trial plans and scaling of manufacture.
FDA looks to accelerate plasma therapies for coronavirus 06-Apr-2020 By Ben Hargreaves US FDA looks to coordinate and speed up the development of blood-derived therapies to treat patients with COVID-19.
J&J chooses lead coronavirus candidate, sets up manufacturing for 1 billion doses 30-Mar-2020 By Ben Hargreaves The company provides update on its coronavirus plans, which includes $1bn in funding to research and expected Phase I trial commencement date.
Roche’s treatment for coronavirus enters Phase III 19-Mar-2020 By Ben Hargreaves Roche looks to repurpose its arthritis medicine for use against the coronavirus, after China previously endorsed its use.
Pharma events update: rescheduled, canceled, online 18-Mar-2020 By Jenni Spinner This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.
Gates Foundation, Wellcome and Mastercard partner to combat coronavirus 12-Mar-2020 By Ben Hargreaves The three organizations set up the COVID-19 Therapeutics Accelerator, backing the initiative with $125m.